Trial · NCT02923921
Adverse events398
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
81 to 100 of 398
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Insomnia | Psychiatric disorders | Pegilodecakin + FOLFOX | 14 | 278 | 14 |
| other | Insomnia | Psychiatric disorders | FOLFOX | 13 | 251 | 13 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Pegilodecakin + FOLFOX | 17 | 278 | 22 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | FOLFOX | 19 | 251 | 22 |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Pegilodecakin + FOLFOX | 30 | 278 | 41 |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | FOLFOX | 15 | 251 | 17 |
| other | Pruritus | Skin and subcutaneous tissue disorders | Pegilodecakin + FOLFOX | 15 | 278 | 24 |
| other | Pruritus | Skin and subcutaneous tissue disorders | FOLFOX | 8 | 251 | 11 |
| other | Rash | Skin and subcutaneous tissue disorders | Pegilodecakin + FOLFOX | 23 | 278 | 34 |
| other | Rash | Skin and subcutaneous tissue disorders | FOLFOX | 9 | 251 | 10 |
| serious | Anaemia | Blood and lymphatic system disorders | Pegilodecakin + FOLFOX | 3 | 278 | 5 |
| serious | Anaemia | Blood and lymphatic system disorders | FOLFOX | 1 | 251 | 2 |
| serious | Febrile neutropenia | Blood and lymphatic system disorders | Pegilodecakin + FOLFOX | 3 | 278 | 3 |
| serious | Febrile neutropenia | Blood and lymphatic system disorders | FOLFOX | 1 | 251 | 1 |
| serious | Neutropenia | Blood and lymphatic system disorders | Pegilodecakin + FOLFOX | 2 | 278 | 3 |
| serious | Neutropenia | Blood and lymphatic system disorders | FOLFOX | 3 | 251 | 4 |
| serious | Thrombocytopenia | Blood and lymphatic system disorders | Pegilodecakin + FOLFOX | 1 | 278 | 1 |
| serious | Thrombocytopenia | Blood and lymphatic system disorders | FOLFOX | 0 | 251 | 0 |
| serious | Acute myocardial infarction | Cardiac disorders | Pegilodecakin + FOLFOX | 0 | 278 | 0 |
| serious | Acute myocardial infarction | Cardiac disorders | FOLFOX | 1 | 251 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02923921/events?page=5